Decisions made by the MHRA following investigations into complaints about advertising for licensed medicines.
Similar Posts
MHRA Safety Roundup: July 2025
Summary of the latest safety advice for medicines and medical device users
Contact the MHRA
How to contact the MHRA for specific services or enquiries.
Field Safety Notices: 28 July to 1 August 2025
List of Field Safety Notices from 28 July to 1 August 2025.
Class 4 Medicines Defect Notification: Erythromycin Stearate BP 250mg Tablets, Amdipharm UK Ltd, EL(25)A/32
Amdipharm UK Ltd has informed MHRA that the Patient information leaflet (PIL) in the cartons for the batch listed in this notification includes a superseded PIL.
Class 2 Medicines Recall: Baxter Healthcare Limited, Compound Sodium Lactate Solution for Infusion BP (Hartmann’s Solution for infusion) in Viaflo 1000ml, EL(25)A/46
Baxter Healthcare is recalling one batch of Compound Sodium Lactate (Hartmann’s Solution) 1000mL. This is due to a packaging error where some cartons labelled as Hartmann’s Solution may contain Ringer’s Solution 1000mL.
Field Safety Notices: 27 to 31 October 2025
List of Field Safety Notices from 27 to 31 October 2025.